Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Vinz
    Member
    • Dec 2010
    • 80

    #76
    We are using the 500 cycle kits for amplicon sequencing with about 20 different amplicons. After applying hardcoded settings it looks ok now. Not as nice as a phiX. But we get usually above 75%Q30. The last 50 bases of the reverse read quality drops (20 to 50% below Q20).

    Comment

    • LVAndrews
      Member
      • Sep 2012
      • 55

      #77
      Originally posted by pmiguel View Post
      Also, it was my understanding that the new MCS version 2.1.1.13 had some improvements for handling low diversity data. Anyone seen evidence of this?

      --
      Phillip
      I had thought this as well, but my first amplicon run after the update didn't seem too great. I asked our FAS and she said it was mainly meant to prevent the intensity spikes that result from high phasing/prephasing values, not to really address the low-complexity problem.

      Comment

      • LVAndrews
        Member
        • Sep 2012
        • 55

        #78
        Originally posted by Vinz View Post
        We are using the 500 cycle kits for amplicon sequencing with about 20 different amplicons. After applying hardcoded settings it looks ok now. Not as nice as a phiX. But we get usually above 75%Q30. The last 50 bases of the reverse read quality drops (20 to 50% below Q20).
        Vinz, are you using barcoded primers for sample prep or do you have universal adapters instead? I am interested in using the Y-adapters from the Kozarewa and Turner protocol for T/A cloning amplicons since this would make our adapters universal for any amplicon, but I'm not sure if template orientation will be a problem in downstream analysis since at least with barcoded primers, orientation is always the same whereas with Kozarewa adapters, the reads will go either way. This would have the added benefit of increasing complexity and one could even move the index to the front of read 1 for 12 cycles to increase complexity during the initial part of the run. The Caporaso paper insisted on a separate index read mainly because Hiseq reads were so short, but in the era of 300 and 500 cycle kits this seems less important to me now.

        Comment

        • Vinz
          Member
          • Dec 2010
          • 80

          #79
          We use the 4 primer approach with dual indexing (see this post). Meaning, we do only 1 PCR which includes a target specific PCR including universal adapters and outer primers which will add the indexes and flow cell sequences. I guess it depends on how many different amplicons you want to target. If you have a low level of targets and multiplexing, then your approach might be worth while.

          Comment

          • LVAndrews
            Member
            • Sep 2012
            • 55

            #80
            Originally posted by Vinz View Post
            We use the 4 primer approach with dual indexing (see this post). Meaning, we do only 1 PCR which includes a target specific PCR including universal adapters and outer primers which will add the indexes and flow cell sequences. I guess it depends on how many different amplicons you want to target. If you have a low level of targets and multiplexing, then your approach might be worth while.
            That's fantastic. Exactly what I've been looking for. We're new to providing miseq service and it seems like everyone wants a different locus (which I totally understand).

            Comment

            • boscoliveira
              Junior Member
              • Jul 2010
              • 8

              #81
              Originally posted by AKrohn View Post
              That's fantastic. Exactly what I've been looking for. We're new to providing miseq service and it seems like everyone wants a different locus (which I totally understand).
              Hi Vinz, would the following primers work (including 12N to try to solve the low diversity problem), Nextera style (using the transposase sequence available in the Illumina Letter):

              PCR1F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGNNNNNNNNNNNNSEQUENCESPECIFICPRIMER
              PCR1R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGNNNNNNNNNNNNSEQUENCESPECIFICPRIMER

              PCR2F AATGATACGGCGACCACCGAGATCTACAC[i5]TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG

              PCR2R CAAGCAGAAGACGGCATACGAGAT[i7]GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG

              Comment

              • TonyBrooks
                Senior Member
                • Jun 2009
                • 303

                #82
                Originally posted by AKrohn View Post
                I had thought this as well, but my first amplicon run after the update didn't seem too great. I asked our FAS and she said it was mainly meant to prevent the intensity spikes that result from high phasing/prephasing values, not to really address the low-complexity problem.
                Apparently the new version of RTA is significantly better at low diversity. Phasing calculations are done empirically for every cycle, whereas previously the first 12 cycles were used as an estimate for the whole run.
                Colour correction is now also estimated over more cycles too making the matrix a bit more robust.
                Our area rep presented some data on this recently with a 900k/mm2 loading density, 90% PF with <5% PhiX. It comes with the warning that this isn't a magic fix. It still depends a little bit on what's exactly in your library but it does seem to improve data quality for single amplicon libraries.

                We're yet to give it a go. We're thinking of starting with a 15% PhiX spike-in and titrating down as we go.
                Attached Files

                Comment

                • Vinz
                  Member
                  • Dec 2010
                  • 80

                  #83
                  I have not tried nextera style sequencing primers. All I can say is that until the indexes the sequence looks good.
                  Our attempts with 12 Ns were not too encouraging. We had the impression that introducing the 12 Ns resulted in more artefacts (short dimers).
                  Anyway, as Tony stated, the new software works really well. We spike in around 10% phiX with good success. Hardcoded phasing/matrix does not seem to be required anymore. So I would not recommend the 12 N approach.

                  Comment

                  • GW_OK
                    Senior Member
                    • Sep 2009
                    • 411

                    #84
                    You guys should really try phase-shifting-N primers. Have a few sets of primers with varying numbers of N before your amplicon (N, NN, NNN). This gets the identical regions of each sample out of sequence phase with each other. Works well for us so far.

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
                      by SEQadmin2




                      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
                      Today, 06:46 AM
                    • SEQadmin2
                      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                      by SEQadmin2



                      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                      ...
                      10-14-2026, 09:55 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, 10-28-2026, 09:57 AM
                    0 responses
                    22 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 10-28-2026, 09:51 AM
                    0 responses
                    15 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 10-22-2026, 11:13 AM
                    0 responses
                    68 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 10-22-2026, 10:48 AM
                    0 responses
                    48 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...